Skip to main content
. 2018 Jan 26;9(2):128. doi: 10.1038/s41419-017-0141-1

Fig. 6. Eltrombopag does not improve the colony-forming potential of SAA-iPSC-derived-hematopoietic progenitors.

Fig. 6

a Schematic of the experimental design used to analyze the effect of eltrombopag on the colony-forming potential, proliferation and DNA repair capacity in SAA-iPSC based hematopoietic progenitors; bd Analysis of CFUs generated in DMSO (dark blue bars) and eltrombopag-treated (orange bars) iPSC-derived-hematopoietic progenitors in WT and SAA cell lines in non-replicative stress conditions; b Total CFUs, c erythroid-lineage CFUs, d myeloid-lineage CFUs. eg Analysis of CFUs generated in DMSO (red bars) and eltrombopag-treated (grey bars) iPSC-derived-hematopoietic progenitors in WT and SAA cell lines under replicative stress conditions: e Total CFUs, f erythroid-lineage CFUs, g myeloid-lineage CFUs. bg Multiple t-test using Holm-Sidak method was used for statistical comparison between DMSO and eltrombopag groups. Data is presented as mean of at least 3 independent experiments ± S.E.M. Data for all control cell lines is averaged in one group (WT)